Javed Mahmood1, Salomeh Jelveh2, Asif Zaidi3, Susan R Doctrow4, Meetha Medhora5, Richard P Hill6. 1. Ontario Cancer Institute and the Campbell Family Institute for Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Radiation Medicine Program, STTARR Innovation Centre, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. 2. Radiation Medicine Program, STTARR Innovation Centre, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. 3. Ontario Cancer Institute and the Campbell Family Institute for Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. 4. Pulmonary Center, Department of Medicine, Boston University, Boston, Massachusetts. 5. Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin. 6. Ontario Cancer Institute and the Campbell Family Institute for Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. Electronic address: hill@uhnres.utoronto.ca.
Abstract
PURPOSE: To investigate the outcome of suppression of the renin angiotensin system using captopril combined with an antioxidant (Eukarion [EUK]-207) for mitigation of radiation-induced lung damage in rats. METHODS AND MATERIALS: The thoracic cavity of female Sprague-Dawley rats was irradiated with a single dose of 11 Gy. Treatment with captopril at a dose of 40 mg/kg/d in drinking water and EUK-207 given by subcutaneous injection (8 mg/kg daily) was started 1 week after irradiation (PI) and continuing until 14 weeks PI. Breathing rate was monitored until the rats were killed at 32 weeks PI, when lung fibrosis was assessed by lung hydroxyproline content. Lung levels of the cytokine transforming growth factor-β1 and macrophage activation were analyzed by immunohistochemistry. Oxidative DNA damage was assessed by 8-hydroxy-2-deoxyguanosine levels, and lipid peroxidation was measured by a T-BARS assay. RESULTS: The increase in breathing rate in the irradiated rats was significantly reduced by the drug treatments. The drug treatment also significantly decreased the hydroxyproline content, 8-hydroxy-2-deoxyguanosine and malondialdehyde levels, and levels of activated macrophages and the cytokine transforming growth factor-β1 at 32 weeks. Almost complete mitigation of these radiation effects was observed by combining captopril and EUK-207. CONCLUSION: Captopril and EUK-207 can provide mitigation of radiation-induced lung damage out to at least 32 weeks PI after treatment given 1-14 weeks PI. Overall the combination of captopril and EUK-207 was more effective than the individual drugs used alone.
PURPOSE: To investigate the outcome of suppression of the renin angiotensin system using captopril combined with an antioxidant (Eukarion [EUK]-207) for mitigation of radiation-induced lung damage in rats. METHODS AND MATERIALS: The thoracic cavity of female Sprague-Dawley rats was irradiated with a single dose of 11 Gy. Treatment with captopril at a dose of 40 mg/kg/d in drinking water and EUK-207 given by subcutaneous injection (8 mg/kg daily) was started 1 week after irradiation (PI) and continuing until 14 weeks PI. Breathing rate was monitored until the rats were killed at 32 weeks PI, when lung fibrosis was assessed by lung hydroxyproline content. Lung levels of the cytokine transforming growth factor-β1 and macrophage activation were analyzed by immunohistochemistry. Oxidative DNA damage was assessed by 8-hydroxy-2-deoxyguanosine levels, and lipid peroxidation was measured by a T-BARS assay. RESULTS: The increase in breathing rate in the irradiated rats was significantly reduced by the drug treatments. The drug treatment also significantly decreased the hydroxyproline content, 8-hydroxy-2-deoxyguanosine and malondialdehyde levels, and levels of activated macrophages and the cytokine transforming growth factor-β1 at 32 weeks. Almost complete mitigation of these radiation effects was observed by combining captopril and EUK-207. CONCLUSION:Captopril and EUK-207 can provide mitigation of radiation-induced lung damage out to at least 32 weeks PI after treatment given 1-14 weeks PI. Overall the combination of captopril and EUK-207 was more effective than the individual drugs used alone.
Authors: Victoria L Calveley; Salomeh Jelveh; Aimee Langan; Javed Mahmood; Ivan W T Yeung; Jake Van Dyk; Richard P Hill Journal: Radiat Res Date: 2010-05 Impact factor: 2.841
Authors: Swarajit N Ghosh; Rong Zhang; Brian L Fish; Vladimir A Semenenko; X Allen Li; John E Moulder; Elizabeth R Jacobs; Meetha Medhora Journal: Int J Radiat Oncol Biol Phys Date: 2009-12-01 Impact factor: 7.038
Authors: Hannah J Zhang; Susan R Doctrow; Linjing Xu; Larry W Oberley; Benjamin Beecher; Joanna Morrison; Terry D Oberley; Kevin C Kregel Journal: FASEB J Date: 2004-08-19 Impact factor: 5.191
Authors: Hongmei Wang; Zhongxing Liao; Yan Zhuang; Ting Xu; Quynh-Nhu Nguyen; Lawrence B Levy; Michael O'Reilly; Kathryn A Gold; Daniel R Gomez Journal: Int J Radiat Oncol Biol Phys Date: 2013-10-22 Impact factor: 7.038
Authors: Whitney D Gannon; Michaela R Anderson; Anna J Podolanczuk; Steven M Kawut; Erin D Michos; Vincent Cottin; Michael Kreuter; Ganesh Raghu; R Graham Barr; David J Lederer Journal: Ann Am Thorac Soc Date: 2019-11
Authors: Tyler A Beach; Angela M Groves; Carl J Johnston; Jacqueline P Williams; Jacob N Finkelstein Journal: Int J Radiat Biol Date: 2018-09-21 Impact factor: 2.694
Authors: Chris D Johnstone; Patricia Lindsay; Edward E Graves; Eugene Wong; Jessica R Perez; Yannick Poirier; Youssef Ben-Bouchta; Thilakshan Kanesalingam; Haijian Chen; Ashley E Rubinstein; Ke Sheng; Magdalena Bazalova-Carter Journal: Phys Med Biol Date: 2017-06-26 Impact factor: 3.609
Authors: Jacqueline P Williams; Laura Calvi; Joe V Chakkalakal; Jacob N Finkelstein; M Kerry O'Banion; Edward Puzas Journal: Radiat Res Date: 2016-06-22 Impact factor: 2.841